TCAR中血流逆转不耐受的危险因素及术中管理
本研究回顾性分析ROADSTER和ROADSTER-2试验中清醒状态下接受TCAR的患者,比较血流逆转不耐受与耐受患者的人口学、手术细节及解剖因素,发现不耐受发生率低且所有病例均成功完成,COPD和对侧颈动脉闭塞呈接近显著的趋势。
要点
- TCAR中血流逆转不耐受发生率低,所有病例经调整流速或麻醉方式后成功完成。
- 糖尿病、高血压、高脂血症等合并症与不耐受无显著关联。
- COPD和对侧颈动脉闭塞与不耐受存在接近显著的趋势。
核心结论
- 尽管出现血流逆转不耐受,通过调整逆转流速可成功完成TCAR,通常无需转为全身麻醉。
- COPD和对侧颈动脉闭塞与不耐受存在接近显著的趋势,但机制尚不明确。
研究设计与样本
- 回顾性分析ROADSTER和ROADSTER-2多中心试验中前瞻性收集的数据。
- 共纳入103例来自ROADSTER和194例来自ROADSTER-2在局部/区域麻醉下接受TCAR的患者。
主要发现
- 8例患者出现血流逆转不耐受,所有病例均成功完成。
- 8例不耐受患者中仅5例有术中血流动力学数据,均未出现低血压。
- 4例在低流速逆转下完成,3例经数分钟从低流速成功过渡至高流速,1例需全身麻醉。
- 不耐受与糖尿病、高血压、高脂血症、充血性心力衰竭、既往心梗或心绞痛、术前CAS相关症状、既往卒中、既往CAS或CEA、颈部放疗史、串联狭窄、高位颈动脉狭窄或困难颈部无显著关联。
- COPD和对侧颈动脉闭塞呈接近显著的趋势(P值分别为0.086和0.139)。
关键数值与推荐
- ROADSTER1/2试验数据显示TCAR中血流逆转不耐受观察率为1-2%,而CEA清醒干预中约12%患者不耐受颈内动脉夹闭。
临床怎么用
- 对于TCAR术中发生血流逆转不耐受的患者,可尝试调整逆转流速(如低流速或从低到高过渡)来完成手术。
- 应关注合并COPD或对侧颈动脉闭塞的患者,其不耐受风险可能较高。
局限性
- 不耐受患者数量少(8例),且仅5例有术中血流动力学数据。
- 回顾性研究设计,不耐受判定由术者决定,可能存在偏倚。
- 样本量不足以明确不耐受的危险因素,需更大样本研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients deemed high risk for carotid endarterectomy (CEA) who are indicated for treatment of carotid artery stenosis (CAS), transcarotid artery revascularization (TCAR) has been demonstrated as a safe and effective alternative to trans-femoral carotid artery stenting (TF-CAS). Compared to CEA, where approx. 12% of patients undergoing awake intervention do not tolerate internal carotid artery (ICA) clamping, only 1-2% of patients were observed to have intolerance to flow reversal during TCAR based on data from the ROADSTER1/2 trials. This study reviewed awake interventions from those trials to assess factors associated with intolerance to flow reversal and review how those cases were managed. METHODS: This is a retrospective review of prospectively collected data from Reverse Flow Used During Carotid Artery Stenting Procedure (ROADSTER) multicenter trial along with the subsequent post-approval (ROADSTER-2) trial. The subset of patients from both trials undergoing awake TCAR was analyzed to compare demographics, procedural details, and anatomic factors between patients who did and did not experience intolerance to reversal of flow to assess for predisposing factors. Patients were deemed intolerant to flow reversal at the discretion of the operator, often related to changes in completion of neurologic tasks, hemodynamic stability, or patient reported symptoms. RESULTS: A total of 103 patients from ROADSTER and 194 patients from ROADSTER-2 underwent TCAR under local/regional anesthesia. Of these, 8 patients had intolerance to flow reversal, though all cases were successfully completed. While intraoperative hemodynamic data was only available for 5 of the 8 intolerant patients, none experienced hypotension. 4 cases were completed under low flow reversal, 3 cases were successfully weaned from low to high flow over several minutes, and 1 case required general anesthesia. No significant association was found between intolerance to flow reversal and comorbidities including diabetes mellitus (DM), hypertension (HTN), hyperlipidemia (HLD), congestive heart failure (CHF), prior MI or angina, pre-op CAS-related symptoms, prior stroke, prior CAS or CEA, prior neck radiation, tandem stenosis, high cervical stenosis, or hostile neck. A trend towards significance was seen with chronic obstructive pulmonary disease (COPD) and contralateral carotid artery occlusion (P = 0.086 and 0.139, respectively). CONCLUSIONS: Despite intolerance to flow reversal, TCAR cases were successfully completed by adjusting reversal-of-flow rate and do not typically require conversion to GETA. While factors contributing to intolerance of flow reversal during TCAR remain poorly understood, this study identified a trend towards significance with an association of preexisting COPD and contralateral carotid artery occlusion. Given the low number of patients who experienced this issue, a larger sample size is required to better elucidate these trends.
引用
- Teter K, Rockman C, Lamparello P, et al. Risk Factors for and Intraoperative Management of Intolerance to Flow Reversal in TCAR. Ann Vasc Surg. 2021. PMID: 34688872. doi:10.1016/j.avsg.2021.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。